KENNEWICK, Wash., April 22, 2008 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (Pink Sheets:ADMD) (http://www.isotopeworld.com), a company engaging in the production and distribution of medical isotopes, has retained the Investor Relations Group, Inc. ("IRG"), a thirteen-year-old, highly-recognized corporate communications firm based in New York City, to serve as its national public relations and investor relations firm.
The Investor Relations Group's award-winning healthcare public relations department will reach out to the media-at-large, namely editors, writers, and producers of local and national trade and consumer print, radio, broadcast, and online media outlets, with the primary focus of educating the public about the unique materials and potential products of AMIC. Simultaneously, IRG's investor relations team will use proprietary competitive analysis strategies and extensive databases to target the broad scope of the investment community, including portfolio managers and analysts. The program will include pre-qualified one-on-one introductions, e-mail to those that have opted-in for communication, and general traditional outreach.
"Advanced Medical Isotope envisions a future in which medical isotopes are both more economical and accessible," said James C. Katzaroff, Chairman and President. "At present, approximately 90% of the medical isotopes used in hospitals and clinics are imported, and America's supply of medical isotopes is at risk. As we move forward with our vision to grow the company, the Investor Relations Group will play an integral part in communicating AMIC's message to the investment community, the media, and the public at large."
About The Investor Relations Group, Inc.
The Investor Relations Group, Inc. (IRG) offers a full-service corporate communications program designed to suit the many unique needs of Alternative Public Offering (APO) companies. The program utilizes a proprietary, targeted approach to reach institutional investors, analysts, and the media-at-large. For further information, please visit the company's website at www.investorrelationsgroup.com.
About Advanced Medical Isotope Corporation
Advanced Medical Isotope Corporation (AMIC) is a medical isotope production company engaged in the production and distribution of medical isotopes and medical isotope in vivo delivery systems for advanced diagnostic and non-surgical therapeutic application. AMIC's goal is to empower physicians, medical researchers, and ultimately patients by providing them with essential medical isotopes that, until now, have not been feasible or economical, in an effort to detect and cure human disease. For more information, please visit our website, www.isotopeworld.com.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.